• Aucun résultat trouvé

- Medical Device Not applicable

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "- Medical Device Not applicable "

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

Latanoprost/ Pharmathen 50 micrograms /mL preservative free eye drops, solution in multi dose container 2.3.R Regional Information /For Eu, p.1

2.3.R REGIONAL INFORMATION/ FOR EU - Process Validation Scheme for the Drug Product

Process validation protocol for Latanoprost/ Pharmathen 50 micrograms/mL

preservative free eye drops, solution in multi dose container is enclosed in section 3.2.R.

- Medical Device Not applicable

- Certificates of Suitability Not applicable

- Medicinal Products containing or using in the manufacturing process materials of animal and/or human origin

Not applicable

Références

Télécharger maintenant ( PDF - 1 Page - 25.09 KB )

Documents relatifs

Package leaflet: Information for the user [Invented name] 40 micrograms/mL+ 5 mg/mL eye drops, solution

Tell your doctor before you have an operation that you are using [Invented name] as timolol may change effects of some medicines used during anaesthesia.. [Invented name] may

(1)Travoprost-Timolol / Pharmathen (40micrograms/mL+5mg/mL) preservative free eye drops, solution in multi dose container 1.5.2 Information for abridged application 1 1.5

Profile comparison between Travoprost Timolol 0.04mg/ml – 5mg/ml eye drops solution preservative free and DUOTRAV reference products (ALCON) reveals similarity between the

[TRAVOPROST + TIMOLOL] 40 MCG/ML + 5 MG/ML, PRESERVATIVE-FREE EYE DROPS, SOLUTION RISK MANAGEMENT PLAN

Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the

Module 2.5: Clinical Overview Travoprost/Timolol preservative free eye drops solution by Pharmathen

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary

Medical Device Not applicable - Certificates of Suitability Please refer to dossier section 32-reg-info for the current Certificate of Suitability of Timolol maleate

Process validation protocol for Travoprost-Timolol/Pharmathen (40 micrograms/mL + 5 mg/ml) preservative free eye drops, solution in multi dose container is enclosed in

latanoprost; 0,05 mg/ml; eye drops, solution

[r]

NAME OF THE MEDICINAL PRODUCT [Invented name] 50 micrograms/mL eye drops, solution Latanoprost 2

Excipients: Macrogolglycerol hydroxystearate 40, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, anhydrous disodium phosphate, hydrochloric acid or/and

1.5. SPECIFIC REQUIREMENTS FOR DIFFERENT TYPES OF APPLICATIONS 1.5.2. Information for generic, “hybrid” or bio-similar applications Introduction

Latanoprost/ Pharmathen 50 micrograms/mL preservative free eye drops, solution in multi dose container 1.5.2.. Information for generic, hybrid or bio-similar